Drug Type Chemical drugs |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Attention Deficit Disorder With Hyperactivity | Preclinical | US | 05 Jul 2024 | |
Depressive Disorder, Major | Preclinical | US | 05 Jul 2024 | |
Generalized anxiety disorder | Preclinical | US | 05 Jul 2024 |